Johan M Kros Selected Research

Johan M Kros Research Topics

Disease

72	Neoplasms (Cancer) 01/2023 - 08/2002
46	Glioma (Gliomas) 05/2022 - 06/2004
26	Glioblastoma (Glioblastoma Multiforme) 10/2023 - 03/2005
16	Brain Neoplasms (Brain Tumor) 12/2023 - 08/2003
13	Astrocytoma (Pilocytic Astrocytoma) 03/2024 - 03/2002
12	Oligodendroglioma 01/2020 - 03/2002
8	Medulloblastoma 11/2021 - 10/2008
7	Neoplasm Metastasis (Metastasis) 01/2023 - 10/2008
5	Adenoma (Adenomas) 01/2017 - 04/2008
4	Meningioma (Meningiomas) 12/2023 - 12/2005
4	Acromegaly 01/2017 - 01/2013
4	Pituitary Neoplasms (Pituitary Adenoma) 12/2013 - 12/2003
4	Disease Progression 01/2010 - 03/2003
3	Breast Neoplasms (Breast Cancer) 01/2021 - 12/2014
3	Melanoma (Melanoma, Malignant) 01/2017 - 12/2003
3	Alzheimer Disease (Alzheimer's Disease) 01/2015 - 11/2011
3	Carcinogenesis 08/2012 - 04/2004
2	Aneuploidy (Aneuploid) 01/2021 - 08/2002
2	Schmid-Fraccaro syndrome 09/2018 - 01/2017
2	Growth Hormone-Secreting Pituitary Adenoma 01/2017 - 04/2008
2	Dementia (Dementias) 01/2015 - 11/2011
2	Lung Neoplasms (Lung Cancer) 12/2014 - 04/2004
2	Fragile X Tremor Ataxia Syndrome 01/2014 - 09/2006
2	Ependymoma 10/2008 - 06/2007
2	Pituitary ACTH Hypersecretion 05/2004 - 04/2003
2	Carcinoma (Carcinomatosis) 04/2004 - 04/2003
2	Ganglioglioma 08/2002 - 04/2002
1	Hypoxia (Hypoxemia) 12/2023
1	Brain Hypoxia (Cerebral Hypoxia) 12/2023
1	Epilepsy (Aura) 01/2023
1	Central Nervous System Neoplasms 01/2022

Drug/Important Bio-Agent (IBA)

30	Proteins (Proteins, Gene)FDA Link 01/2020 - 03/2002
20	Temozolomide (Temodar)FDA LinkGeneric 03/2024 - 03/2005
13	Biomarkers (Surrogate Marker)IBA 10/2023 - 06/2005
12	Vincristine (Oncovin)FDA LinkGeneric 10/2022 - 02/2005
12	Procarbazine (Matulane)FDA Link 10/2022 - 02/2005
12	Lomustine (CCNU)FDA Link 10/2022 - 02/2005
10	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 01/2022 - 03/2010
8	Messenger RNA (mRNA)IBA 06/2021 - 10/2008
8	ParaffinIBA 02/2016 - 12/2002
8	Formaldehyde (Formol)FDA Link 02/2016 - 12/2002
7	DNA (Deoxyribonucleic Acid)IBA 10/2023 - 08/2002
6	RNA (Ribonucleic Acid)IBA 03/2024 - 12/2013
5	epidermal growth factor receptor VIIIIBA 12/2022 - 12/2007
5	ErbB Receptors (EGF Receptor)IBA 01/2020 - 12/2007
5	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 01/2017 - 04/2008
5	Calmodulin-Binding Proteins (Caldesmon)IBA 02/2009 - 08/2003
4	NucleotidesIBA 11/2021 - 10/2019
4	MethyltransferasesIBA 01/2020 - 03/2002
4	Somatostatin Receptors (Somatostatin Receptor)IBA 01/2017 - 04/2008
3	AntibodiesIBA 05/2022 - 06/2013
3	Bevacizumab (Avastin)FDA Link 01/2022 - 02/2016
3	Protein Isoforms (Isoforms)IBA 01/2019 - 04/2007
3	Growth Hormone (Somatotropin)IBA 01/2017 - 03/2008
3	Octreotide (Sandostatin)FDA LinkGeneric 01/2017 - 04/2008
3	Monoclonal AntibodiesIBA 02/2016 - 07/2007
3	Tumor Biomarkers (Tumor Markers)IBA 01/2015 - 06/2007
3	ProteomeIBA 06/2012 - 06/2007
2	Immunoglobulins (Immunoglobulin)IBA 05/2022 - 12/2002
2	AutoantibodiesIBA 05/2022 - 03/2003
2	AntigensIBA 05/2022 - 10/2019
2	Peptides (Polypeptides)IBA 05/2022 - 03/2008
2	Tyrosine Kinase InhibitorsIBA 01/2020 - 11/2005
2	Telomerase (Telomerase Reverse Transcriptase)IBA 01/2020 - 12/2013
2	MicroRNAs (MicroRNA)IBA 11/2019 - 01/2011
2	erucylphosphocholineIBA 01/2019 - 04/2007
2	UbiquitinIBA 01/2019 - 09/2006
2	ArrestinsIBA 05/2016 - 12/2013
2	ArrestinIBA 05/2016 - 12/2013
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 02/2016 - 01/2010
2	colligin (CBP2)IBA 10/2010 - 01/2010
2	Carmustine (FIVB)FDA Link 03/2009 - 06/2008
2	S100 Proteins (S 100 Protein)IBA 03/2009 - 04/2002
2	CollagenIBA 03/2009 - 12/2005
2	Imatinib Mesylate (Gleevec)FDA Link 10/2008 - 11/2005
2	Dopamine Receptors (Dopamine Receptor)IBA 04/2008 - 05/2004
2	Dopamine Agonists (Dopamine Agonist)IBA 04/2008 - 05/2004
2	Glial Fibrillary Acidic ProteinIBA 03/2008 - 04/2002
2	TubulinIBA 03/2008 - 04/2002
2	A-Form DNA (A-DNA)IBA 06/2007 - 03/2002
2	Alkylating AgentsIBA 03/2005 - 03/2002
2	Adrenocorticotropic Hormone (ACTH)FDA Link 05/2004 - 04/2003
1	Oxygen (Dioxygen)IBA 12/2023
1	Anticonvulsants (Antiepileptic Drugs)IBA 01/2023
1	1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA 01/2023
1	Peptide Receptors (Peptide Receptor)IBA 01/2023
1	Radioisotopes (Radionuclides)IBA 01/2023
1	Cyclin-Dependent Kinase 4IBA 01/2023
1	Peptide LibraryIBA 05/2022
1	APTIBA 02/2022
1	Angiogenesis InhibitorsIBA 01/2022
1	Cell-Free Nucleic AcidsIBA 01/2021
1	Circulating Tumor DNAIBA 01/2021

Therapy/Procedure

33	Drug Therapy (Chemotherapy) 10/2022 - 03/2002
26	Radiotherapy 12/2023 - 03/2003
22	Therapeutics 01/2023 - 07/2007
4	Precision Medicine 10/2023 - 07/2015
4	Lasers (Laser) 03/2008 - 08/2003
2	Immunotherapy 01/2023 - 01/2018
2	Chemoradiotherapy 01/2020 - 01/2016